Rhodes DeRetta C. 4

4 · Atlanta Braves Holdings, Inc. · Filed Dec 8, 2025

Form 4

Period: 2025-12-04

EVP, Chief Culture Officer

Transactions

Exercise/Conversion
Series C Common Stock
2025-12-04+3,375→ 6,487 total
Sale
Series C Common Stock
2025-12-05$38.70/sh−1,501$58,089→ 4,986 total
Exercise/Conversion
Restricted Stock Units - BATRK
2025-12-04−3,375→ 0 total
From: 2025-12-04Exp: 2025-12-04→ Series C Common Stock (3,375 underlying)
Award
Restricted Stock Units - BATRK
2025-12-04+3,499→ 3,499 total
From: 2026-12-04Exp: 2026-12-04→ Series C Common Stock (3,499 underlying)

Footnotes (4)

[F1]Each restricted stock unit converted into one share of Series C Common Stock.
[F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
[F3]Reflects the weighted average sale price. The range of prices for such transaction is $38.57 to $38.79. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
[F4]Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

Documents

1 file